What Is Lecanemab? FDA Accelerates Approval For Early Alzhei

The FDA granted accelerated approval to Lecanemab — an experimental drug that will be marketed as Leqembi and likely spark considerable interest from patients and physicians across the country.

Related Keywords

United States , Japan , Japanese , Americans , American , Billy Dunn , Centers For Medicare , Drug Administration , Medicaid Services , Office Of Neuroscience , Drug Evaluation , New England Journal , National , Alzheimers Disease , Alzheimers Treatment , Drug , New Treatment , Medicine , Health , Fda , Experimental , Alzheimer S , Dementia , Dementia Prevention ,